Page last updated: 2024-08-21

chlormethiazole and Infarction, Middle Cerebral Artery

chlormethiazole has been researched along with Infarction, Middle Cerebral Artery in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hess, DC	1
Cross, AJ; Green, AR; Jones, JA; Murray, TK; Sydserff, SG	1

Other Studies

2 other study(ies) available for chlormethiazole and Infarction, Middle Cerebral Artery

Article	Year
NXY-059: a hopeful sign in the treatment of stroke. Stroke, 2006, Volume: 37, Issue:10 Topics: Animals; Benzenesulfonates; Callithrix; Chlormethiazole; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Fibrinolytic Agents; Free Radical Scavengers; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitrogen Oxides; Pyridines; Randomized Controlled Trials as Topic; Research Design; Rodentia; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2006
Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations. Brain research, 2000, Apr-17, Volume: 862, Issue:1-2 Topics: Animals; Arterial Occlusive Diseases; Chlormethiazole; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Ischemic Attack, Transient; Male; Neuroprotective Agents; Prosencephalon; Rats; Rats, Long-Evans	2000

Article

Year

NXY-059: a hopeful sign in the treatment of stroke.

Stroke, 2006, Volume: 37, Issue:10

Topics: Animals; Benzenesulfonates; Callithrix; Chlormethiazole; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Fibrinolytic Agents; Free Radical Scavengers; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitrogen Oxides; Pyridines; Randomized Controlled Trials as Topic; Research Design; Rodentia; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2006

Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations.

Brain research, 2000, Apr-17, Volume: 862, Issue:1-2

Topics: Animals; Arterial Occlusive Diseases; Chlormethiazole; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Ischemic Attack, Transient; Male; Neuroprotective Agents; Prosencephalon; Rats; Rats, Long-Evans

2000